Articles & Research

GICS forces every company into one sector — distorting the ETFs built on top of it. A modern, multi-dimensional taxonomy gives a truer view of a portfolio's real exposures.

A fund built at the intersection of healthcare and AI can sharpen a portfolio's healthcare allocation.

The U.S. ETF universe now outnumbers listed stocks — but more choice hasn't produced better outcomes. The real gap is analytical, not product-driven.

AI in healthcare requires a different set of standards — and most companies aren't there yet.

Ambient AI is transforming clinical documentation — and what it means for the future of the exam room.

Examining the downstream policy changes that stand to reshape the healthtech investment landscape.

AI agents hold enormous promise in healthcare, but only if we keep the human at the center.

Healthcare AI requires distinct regulatory and ethical frameworks that generic AI deployments simply don't address.

Caring for our aging population is going to look very different — and HealthTech is at the center of it.

Health policy changes will have profound implications for HealthTech investors.

Active ETFs are reshaping how investors think about portfolio construction — and the platforms built to support them.

Healthcare demonstrates a distinct kind of economic resilience. Here's why that matters for investors.

The case for active ETFs goes beyond returns — diversification, tax efficiency, and transparency all play a role.

Tariffs create supply chain disruptions with meaningful downstream consequences for HealthTech.

Why a disciplined, recurring investment strategy may be the smartest way to build HealthTech exposure.

AI is beginning to address some of the most entrenched workforce constraints in the healthcare system.

A monthly compilation of the most important developments across the HealthTech sector.

As more technology enters the field, the risks grow too — and cybersecurity has never mattered more.

A monthly compilation of the most important developments across the HealthTech sector.

GLP-1 medications are transforming healthcare — but the long-term picture is more nuanced than the headlines suggest.

A monthly compilation of the most important developments across the HealthTech sector.

More information is hardly useful unless there are clear steps people can actually take afterward.

AI is enhancing radiological diagnostics in ways that augment — not replace — physician capabilities.

A monthly compilation of the most important developments across the HealthTech sector.

Policy frameworks are evolving to protect stakeholders utilizing AI — here's what investors need to know.

Efficiency in hospitals is paramount to ensuring care delivery — and technology is reshaping what that looks like.

Technology is reshaping biopharma, but the path from promise to commercial reality remains uncertain.

Changes in biopharma continue to bring about new advancements — but separating signal from noise matters.

Robotics applications in healthcare settings are expanding fast — with real implications for investors.

A novel approach to mental health challenges that addresses the root causes, not just the symptoms.

The relationship between government and industry on drug pricing is far more complex than the headlines suggest.

Half the population stands to benefit from this growth — and the investment opportunity is significant.

Not all areas of the healthcare industry can use this technology effectively — here's what to watch.

Long-term solutions are needed — and technology is starting to provide some answers.

Much needs to be done to make value-based care work at scale — and technology is both the problem and the solution.

An innovative technology using laughter therapeutically — one of the more unexpected HealthTech stories of the year.

Surgical advancements are coming fast — and the implications for patients and investors are significant.

AI can save physicians time and still enhance patient care — here's one compelling example.

The pandemic accelerated adoption of life-saving technologies that are now becoming standard of care.

Investing and how investments are chosen has changed — a framework for cutting through the noise.

A grounded look at how large language models are already affecting the healthcare industry.

Defining HealthTech, establishing industry standards, and making the case for why it matters.

ETFs have experienced exponential growth in recent years — and the best of the category is still ahead.